The MRA Policy Pulse

24 July 2013 In News

With our office based in Washington, DC, we have numerous opportunities to contribute to efforts aimed at policy-makers urging them to ensure better outcomes for melanoma patients and those at risk.  Whether we are advocating for increased NIH funding, participating in meetings on Capitol Hill, or highlighting the need...

Read More


Melanoma News Round-Up July 12, 2013

12 July 2013 In News

There was significant melanoma coverage in the healthcare, science, and medical world this week. Click on the following links to recap or to learn more.   Experimental Melanoma Vaccine Shows Promise in Study via WebMD One Tumor Surprisingly More Deadly Than Multiple Melanomas via Medical News Today GSK files melanoma drug combination...

Read More


Learn from my sunscreen mistakes

3 July 2013

Here goes my shameful confession: I work for the Melanoma Research Alliance and I still got a sunburn.  Everyone makes mistakes at a new job, but mine were entirely preventable.

Read More


Melanoma Research Alliance Rings Closing Bell at the New York Stock Exchange

26 June 2013 In Events

[youtube url=http://www.youtube.com/watch?v=_Emq_T2GO5Y] We had a fabulous visibility opportunity yesterday: The Melanoma Research Alliance (MRA) rang the closing bell on the NYSE trading floor on Tuesday, June 25.  Surrounded by MRA leadership and supporters, MRA Co-Founder and Chair Debra Black presided over the ceremony, which signaled the end of the day’s trading.

Read More


Changing Perceptions and Building a Business on Safe Sun: Guest Post by Mott 50

By Monique Moore, Co-Founder, Mott 50 | 20 June 2013 In Allies & Partnerships

Mott 50 Co-Founders Anne Botica Reilly and Monique Moore[/caption] This summer Mott 50 is introducing the Pale is Pretty campaign— a social awareness initiative designed to encourage people to think critically about their sun safety practices and pledge to ‘Practice Safe Sun.’ Our mission at Mott 50 is to...

Read More


A Teenager’s View: Keeping Sun Fun and Avoiding Melanoma

By Langley Grace Wallace | 14 June 2013 In Melanoma Stories

By Langley Grace Wallace Over the past 40 years, melanoma has increased 800% in young women and 400% in young men. Recently, melanoma has become the most common cancer among 25-29 year olds, and even teenagers are developing this deadly skin cancer.

Read More


New Melanoma Stories

13 June 2013 In Melanoma Stories

Melanoma has touched the lives of many people, and MRA is always eager to hear melanoma stories from patients, researchers, family members, and everyone else affected by this disease. We've recently added two more must-read survivor stories to the MRA website, and here's a preview:

Read More


Two MRA-Sponsored Investigators Published Papers in the New England Journal of Medicine

12 June 2013 In News

Two MRA-sponsored investigators recently reported on the clinical testing of immune checkpoint inhibitors targeting a pathway known as PD-1 in the New England Journal of Medicine. This therapeutic approach, whose clinical utility was established by the FDA approval of ipilimumab in 2011, has produced promising data in patients with advanced melanoma.

Read More


Melanoma News Round-Up June 7, 2013

7 June 2013 In News

Promising New Cancer Drugs Empower the Body's Own Immune System via the New York Times MSK Researchers Report Major Advances in Treatment for Metastatic Eye and Skin Melanoma via Memorial Sloan Kettering Meet the New Class of Drugs Being Deployed in the the Struggle Against Cancer: Checkpoint Blockade via the Economist For a...

Read More


New Melanoma Therapies Approved

31 May 2013 In News

[caption id="attachment_200" align="aligncenter" width="576"] © Ladyminnie | Dreamstime Stock Photos & Stock Free Images[/caption] These are the best types of posts to write:  On Wednesday, the US Food and Drug Administration (FDA) approved two genetically-targeted melanoma therapies as well as a companion diagnostic test that will be used to determine...

Read More


Login

×